$ITGR

Integer Holdings (ITGR): Patience Rewarded as KKR Buyout Delivers 70%+ Premium

Heartland Value Fund's Q3 2026 letter notes Integer Holdings (ITGR) gained 61.41% YTD, closing at $126.52. KKR agreed to acquire ITGR for $127/share, a 70%+ premium to the fund's average cost. ITGR's market cap is $4.3B. The fund underperformed in Q3 due to macroeconomic concerns, with the Russell 2000 Value Index down 4.91%.

Original reporting
Published Oct 13, 2026, 2:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 2:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Integer Holdings (ITGR): Patience Rewarded as KKR Buyout Delivers 70%+ Premium — source image
Decision brief

The 30-second read

$ITGRBullishHigh
01

Why it matters

The acquisition announcement provides a clear catalyst, likely pushing the stock toward the deal price.

02

Market read

A high-premium acquisition of a mid-cap healthcare company, offering immediate trading opportunity.

03

What to watch

Potential antitrust review and financing terms may affect deal completion timeline.

Relevance 9/10Novelty 9/10Timing: today

Background

Integer Holdings (ITGR) is a medical device contract development and manufacturing organization. The stock had risen 61% YTD before the deal.

Company-level read

Ticker impact

$ITGRBullishHigh confidence
Context

KKR announced agreement to acquire Integer Holdings at $127 per share, a >70% premium to recent price.

Expected impact

likely upward pressure as market prices in the acquisition premium

Evidence & confidence

The announced acquisition price is well above current trading levels, creating immediate upside for shareholders.

Market effects

May boost sentiment for other medical device CDMOs as consolidation accelerates.

Limited to US healthcare sector, no broad regional effect.

Highlights continued private equity interest in healthcare manufacturing.

Counterpoint

Deal could face regulatory scrutiny or integration risks, tempering upside.

Key entities

  • Integer Holdings

    Medical device CDMO target of KKR acquisition.

  • KKR

    Private equity firm acquiring ITGR.

Related articles

$ITGRHighAI 9/10

Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR

Integer Holdings Corp (ITGR) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR PLANO, Texas, September 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading global medical device contract

$KKRHighAI 8/10

KKR Secures $2.1B Loan for Integer Buyout

KKR secured a $2.1B loan for its $5.7B acquisition of Integer, with strong investor demand tightening terms. The loan was priced at 2.5% over benchmark, up to 0.5% tighter than initial discussions. Citigroup led the sale. Bloomberg data shows limited LBO financing this year, driving high demand. KKR aims to complete the Integer buyout by year-end, signaling robust credit market activity.

$KKRHighAI 8/10

KKR finalizes $2.1 billion loan to fund Integer acquisition

KKR & Co. (KKR) secured a $2.1 billion loan to finance its $5.7 billion acquisition of Integer Holdings (ITGR), with improved borrowing terms due to strong investor demand. The loan was priced at 2.5 percentage points above its benchmark, lower than initially discussed. The transaction is expected to close by the end of 2026, with Citigroup (C) leading the loan sale. KKR shares fell 1.9% on Friday, while Integer shares remained unchanged.

$ITGRHighAI 9/10

How Could KKR's $5.7 Billion Buyout Reshape ITGR for Shareholders?

Integer Holdings (ITGR) agreed to a $5.7B buyout by KKR, offering $127 per share. The deal's completion depends on shareholder and regulatory approvals. ITGR withdrew its financial outlook and canceled its Q2 earnings call. If completed, ITGR will become private and delist from NYSE. ITGR's Q2 sales fell 2.6% YoY to $464.1M, with gross margin contracting to 24.3%.

$ITGRHighAI 9/10

51.8% premium on table in KKR deal for Integer (NYSE: ITGR), if shareholders approve

KKR-affiliated entities plan to acquire Integer Holdings (ITGR) for $127 per share, a 51.8% premium over the unaffected closing price. The deal requires shareholder approval and regulatory clearances. ITGR's board recommends voting in favor, with completion subject to customary conditions. If approved, ITGR will become a subsidiary of the buyer and cease trading on NYSE.